Halazone

This classification denotes an anti-infective agent with the molecular formula C7H5Cl2NO4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier G359OL82VB, chemically known as 4-(n,n-dichlorosulfamoyl)benzoic acid but generally known as halazone, which bears US NIH Compound Identifier 3552. European Medicines Agency schedules Halazone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07993MIG. The term HALAZONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 14, No. 1, 2000, List 43). HALAZONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule halazone under HS 29350090 and SITC 51580. As of Q4 2014, HALAZONE remains the US FDA Preferred Term for this commodity. Halazone bears US NLM identifiers UMLS ID C0164814 and NCI Concept Code C73153. SMILES: CLN(CL)S(=O)(=O)C1CCC(CC1)C(=O)O.